Synthesis yielded a potent hsp90 inhibitor with antiproliferative effects in breast cancer cells, indicating its therapeutic potential.
An efficient synthetic scheme for 5-amino-4-methoxybenzo[ d ]isoxazoles has been developed starting from 3-(5-isopropyl-2,4-dimethoxyphenyl)-6,7-dihydrobenzo[ d ]isoxazole-4(5 H )-one – a scaffold for the preparation of new Hsp90 inhibitors. The key stages in the synthesis included dibromination at position 5, aromatization, and subsequent copper-catalyzed cross-coupling of 5-bromo-4-methoxybenzo[ d ]isoxazole with sodium azide, with simultaneous reduction to 5-amino-4-methoxybenzo[ d ]isoxazole. Using the developed scheme, a potential Hsp90 inhibitor was obtained, which showed high antiproliferative activity against breast cancer cells of BT-474 line (IC 50 = 5 µM) and moderate activity against MCF-7 cells.
No takes yet. Share an insight, caveat, or question.
Varabyeva et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: